close

Register today to unlock Valuecruncher and get unlimited access

  • Get unlimited access to all compartors and data
  • Save and share valuations as well as comment on others
  • Alter and save your favourite comparator companies

Already registered? Please login now

Comparison Analysis (switch to Discounted Cash Flow Analysis)
Dollar39Point79
Implied share price

Buy Undervalued by 16.1%

5% margin of safety What's this?

EV / EBITDA
Use Average
PFE
Pfizer Inc.
JNJ
Johnson & Johnson
Change
NVS
Novartis AG (ADR)
Change
MRK
Merck & Co., Inc.
Change
SGP
Schering-Plough Corporation
Change
13.68 11.9 12.21 13.2 9.04 25.26
All amounts in millions
from last financial year
         
Implied Share Price $39.79 $131.34 $84.24 $96.10 $14.04
Market Cap 207,930 322,696 212,603 171,277 118,198
Net Debt 15,609 -18,515 16,599 12,985 4,798
Enterprise Value (EV) 223,539 304,181 209,620 184,261 51,349
Revenue 48,851 70,074 50,359 39,498 18,502
EBITDA 18,788 24,918 15,880 20,379 2,033
Percent 38.5 % 35.6 % 31.5 % 51.6 % 11.0 %
EBIT 13,631 21,172 10,655 14,004 860
Percent 27.9 % 30.2 % 21.2 % 35.5 % 4.6 %
Balance Sheet          
Total Assets 167,381 133,411 131,556 101,677 28,117
Total Liabilities 102,661 62,261 54,510 57,001 17,588
Shareholders Equity 64,720 71,150 77,046 44,676 10,529.0

Price history

Comments

No comments yet. Login to comment.